{"address1": "4300 El Camino Real", "address2": "Suite 210", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 351 4495", "website": "https://unicycive.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shalabh K. Gupta M.D., MPA", "age": 51, "title": "Founder, Chairman, CEO & President", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1100000, "exercisedValue": 0, "unexercisedValue": 141224}, {"maxAge": 1, "name": "Dr. Pramod  Gupta Ph.D.", "age": 64, "title": "Executive Vice President of Pharmaceutical & Business Operations", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 40969}, {"maxAge": 1, "name": "Mr. Douglas  Jermasek M.B.A.", "age": 62, "title": "Executive Vice President of Corporate Strategy", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 412500, "exercisedValue": 0, "unexercisedValue": 42029}, {"maxAge": 1, "name": "Mr. John W. Townsend CPA", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 197864, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5749, "open": 0.6, "dayLow": 0.5401, "dayHigh": 0.64, "regularMarketPreviousClose": 0.5749, "regularMarketOpen": 0.6, "regularMarketDayLow": 0.5401, "regularMarketDayHigh": 0.64, "payoutRatio": 0.0, "beta": 2.252, "forwardPE": -2.73, "volume": 3670301, "regularMarketVolume": 3670301, "averageVolume": 1018810, "averageVolume10days": 1385830, "averageDailyVolume10Day": 1385830, "bid": 0.5153, "ask": 0.5758, "bidSize": 4, "askSize": 4, "marketCap": 56672616, "fiftyTwoWeekLow": 0.202, "fiftyTwoWeekHigh": 1.6, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 0.58734, "twoHundredDayAverage": 0.523495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 28132554, "profitMargins": 0.0, "floatShares": 54692402, "sharesOutstanding": 103796000, "sharesShort": 1523377, "sharesShortPriorMonth": 795150, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0147, "heldPercentInsiders": 0.06122, "heldPercentInstitutions": 0.60393, "shortRatio": 1.93, "shortPercentOfFloat": 0.015700001, "impliedSharesOutstanding": 103796000, "bookValue": 0.285, "priceToBook": 1.9157895, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -24097000, "trailingEps": -0.46, "forwardEps": -0.2, "enterpriseToEbitda": -0.965, "52WeekChange": -0.60145986, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.546, "targetHighPrice": 9.0, "targetLowPrice": 3.0, "targetMeanPrice": 6.25, "targetMedianPrice": 7.25, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 32347000, "totalCashPerShare": 0.312, "ebitda": -29151000, "totalDebt": 807000, "quickRatio": 3.093, "currentRatio": 3.608, "totalRevenue": 0, "debtToEquity": 2.898, "revenuePerShare": 0.0, "returnOnAssets": -0.62847, "returnOnEquity": -1.4705299, "grossProfits": 0, "freeCashflow": -22025376, "operatingCashflow": -26466000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "UNCY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "preMarketTime": 1743597502, "regularMarketTime": 1743537600, "marketState": "PRE", "regularMarketChangePercent": -5.026956, "regularMarketPrice": 0.546, "shortName": "Unicycive Therapeutics, Inc.", "longName": "Unicycive Therapeutics, Inc.", "exchange": "NCM", "messageBoardId": "finmb_605176729", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketChange": 0.004000008, "preMarketChangePercent": 0.73260224, "preMarketPrice": 0.55, "regularMarketChange": -0.028899968, "regularMarketDayRange": "0.5401 - 0.64", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1018810, "fiftyTwoWeekLowChange": 0.34399998, "fiftyTwoWeekLowChangePercent": 1.7029701, "fiftyTwoWeekRange": "0.202 - 1.6", "fiftyTwoWeekHighChange": -1.054, "fiftyTwoWeekHighChangePercent": -0.65875, "fiftyTwoWeekChangePercent": -60.145985, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.2, "epsCurrentYear": -0.155, "priceEpsCurrentYear": -3.5225806, "fiftyDayAverageChange": -0.041339993, "fiftyDayAverageChangePercent": -0.07038511, "twoHundredDayAverageChange": 0.022504985, "twoHundredDayAverageChangePercent": 0.042989876, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-13", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626096600000, "displayName": "Unicycive Therapeutics", "trailingPegRatio": null}